Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
August 21 2020
September 19-21th 2020 : Defymed is happy to announce that we will assist to the ESMO Virtual Congre...
June 22 2020
Discover the interview of Séverine Sigrist, the Chief Executive and Scientific Officer of Def...